Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-100885
Filing Date
2025-07-31
Accepted
2025-07-31 16:05:28
Documents
70
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q igms-20250630.htm   iXBRL 10-Q 3201079
2 EX-31.1 igms-ex31_1.htm EX-31.1 16217
3 EX-31.2 igms-ex31_2.htm EX-31.2 14911
4 EX-32.1 igms-ex32_1.htm EX-32.1 9663
5 EX-32.2 igms-ex32_2.htm EX-32.2 9632
  Complete submission text file 0000950170-25-100885.txt   11175726

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT igms-20250630.xsd EX-101.SCH 1425787
73 EXTRACTED XBRL INSTANCE DOCUMENT igms-20250630_htm.xml XML 2132555
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

EIN.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)